Redmile Group’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Hold |
2,074,372
| – | – | 0.29% | 39 |
|
|
2025
Q1 | $2.63M | Hold |
2,074,372
| – | – | 0.25% | 46 |
|
|
2024
Q4 | $1.97M | Hold |
2,074,372
| – | – | 0.14% | 55 |
|
|
2024
Q3 | $3.44M | Hold |
2,074,372
| – | – | 0.2% | 51 |
|
|
2024
Q2 | $3.73M | Hold |
2,074,372
| – | – | 0.23% | 51 |
|
|
2024
Q1 | $6.91M | Hold |
2,074,372
| – | – | 0.25% | 64 |
|
|
2023
Q4 | $3.28M | Hold |
2,074,372
| – | – | 0.12% | 59 |
|
|
2023
Q3 | $3.09M | Hold |
2,074,372
| – | – | 0.15% | 56 |
|
|
2023
Q2 | $4.21M | Hold |
2,074,372
| – | – | 0.16% | 61 |
|
|
2023
Q1 | $3.44M | Sell |
2,074,372
-741,824
| -26% | -$1.23M | 0.15% | 61 |
|
|
2022
Q4 | $9.86M | Hold |
2,816,196
| – | – | 0.4% | 47 |
|
|
2022
Q3 | $12.9M | Hold |
2,816,196
| – | – | 0.5% | 47 |
|
|
2022
Q2 | $8.05M | Hold |
2,816,196
| – | – | 0.31% | 53 |
|
|
2022
Q1 | $12.4M | Hold |
2,816,196
| – | – | 0.39% | 51 |
|
|
2021
Q4 | $15.5M | Hold |
2,816,196
| – | – | 0.35% | 52 |
|
|
2021
Q3 | $16.7M | Hold |
2,816,196
| – | – | 0.29% | 58 |
|
|
2021
Q2 | $30.6M | Sell |
2,816,196
-8,213
| -0.3% | -$89.4K | 0.45% | 55 |
|
|
2021
Q1 | $42.9M | Buy |
+2,824,409
| New | +$42.9M | 0.6% | 51 |
|